Wikipedia -WSS

Wikipedia

author：entertainment 2025-09-27 12:56:13 - browse：72

This image provided by Eisai in January 2023 shows vials and packaging for their medication, Leqembi. — Illustration: Alex Hogan/STAT; Photo: Eisai via AP

Seven months after US drug regulators fully approved Biogen’s treatment for Alzheimer’s disease, only about 2,000 patients are taking the medicine nationwide, the company said Tuesday.

Biogen’s chief executive, Christopher A. Viehbacher, said as the firm released fourth-quarter earnings that he had expected the slow uptake and sees considerable demand for the medication. He told reporters that 3,800 patients with early-stage Alzheimer’s have signed up on multiple registries to receive the drug, called Leqembi, as of last month.

Before patients can get the drug, which costs $26,500-a-year, they must undergo a brain scan or a spinal tap to confirm that they have build-up of deposits of a sticky toxic protein called beta-amyloid that is a hallmark of the disease.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Medicare proposal to cover medical devices draws a mixed reaction
Next article： Living with Fabry disease, a condition that causes chronic pain

WSS

What to know about OceanGate, the company behind the missing Titanic submersible

Lecanemab for Alzheimer's is coming. Is the health system ready?

Elizabeth Holmes on track for early release from her 11

Study: Pain burden is higher in Black NFL players than white ones

California’s proposed $25 per hour health care minimum wage

Bulgari apologizes to China for listing Taiwan as a country after online backlash

knowledge

Wikipedia

explore

Apple is now the first public company to be valued at $3 trillion

Threats against the LGBTQIA+ community intensifying: Department of Homeland Security

After affirmative action ruling, medical educators look to 'holistic review'

Biden launches a new push to limit health care costs

Bright Health sells Medicare Advantage business to Molina

Lecanemab for Alzheimer's is coming. Is the health system ready?

The cancer drug shortage isn’t new — and neither are the solutions

Study: Pain burden is higher in Black NFL players than white ones

Medicare details structure of new drug price negotiation program

N.Y. state detects polio case, first in the U.S. since 2013

explore

Bulgari apologizes to China for listing Taiwan as a country after online backlash

Racing yachts have close encounter with pod of orcas near Strait of Gibraltar

Racing yachts have close encounter with pod of orcas near Strait of Gibraltar

HCA discloses massive data breach affecting 11 million patients

Palantir health business leans on meeting customers’ needs

Retired US general questions alleged Putin, Prigozhin meeting

leisure time

entertainment

knowledge

hotspot